Archives
-
TCAIM, OGDH, and Mitochondrial Metabolism
2026-09-28
The 2025 Molecular Cell study identifies TCAIM as a mitochondrial DNAJC co-chaperone that selectively binds native OGDH and promotes its reduction through HSPA9 and LONP1. This finding expands the role of mitochondrial proteostasis from protein folding toward active control of metabolic enzyme abundance, OGDH complex activity, and carbohydrate catabolism.
-
Clozapine and Circuit Neuroscience: Better Assay Logic
2026-09-28
Clozapine is an atypical antipsychotic medication whose receptor and ERK1/2 effects make it useful for carefully designed schizophrenia research. This article explains how to pair pharmacological experiments with new circuit-level findings without mistaking behavioral convergence for a shared mechanism.
-
Cyanidin Chloride in Oxidative Stress Workflows
2026-09-27
Use Cyanidin Chloride to connect cell-free radical-scavenging assays with cellular inflammation and barrier readouts—while keeping aglycone evidence distinct from studies of related glycosides. This practical workflow highlights dose finding, assay controls, and troubleshooting for oxidative stress research.
-
Cecal Microbiome Responses to E. tenella Treatments
2026-09-26
This study paired 16S rRNA gene sequencing with LC-MS/MS metabolomics to examine how ethanamizuril and sulfachlorpyridazine, alone or together, relate to cecal changes in chickens infected with Eimeria tenella. The results distinguish the apparent microbiota and metabolite responses to each treatment and show why low-dose combination effects should be assessed rather than assumed.
-
Caffeine Workflows for Cancer and Metabolic Research
2026-09-25
Use Caffeine to build controlled, dose-aware experiments in cancer cell inhibition and metabolic regulation—not as a stand-in for target-specific cardiac compounds. This guide connects practical cell-based workflows with the limits and assay-design lessons of new ALDH2 activator research.
-
SB202190 in CRC Organoid–Treg Assays
2026-09-25
Explore how SB 202190 can be used as a carefully controlled p38 MAP kinase inhibitor perturbation in colorectal cancer organoid–Treg studies. This guide connects the compound’s pharmacology to a recent organoid co-culture model while distinguishing published findings from testable hypotheses.
-
TCAIM Tunes OGDH Abundance and Mitochondrial Metabolism
2026-09-24
A 2025 Molecular Cell study identifies the mitochondrial DNAJC co-chaperone TCAIM as a specific binder of native OGDH that lowers its protein abundance through HSPA9 and LONP1. The work connects mitochondrial protein quality control to reduced OGDH-complex activity and carbohydrate catabolism, revealing a post-translational route for adjusting metabolism.
-
Camptothecin: From DNA Damage to Adaptation
2026-09-24
Camptothecin is a topoisomerase I inhibitor for studying DNA damage, cell fate, and stress responses. This article connects its acute cellular effects to new research on heritable mutability—and explains why those distinct timescales require distinct assays.
-
TCAIM Controls OGDH and Mitochondrial Metabolism
2026-09-23
The study identifies the mitochondrial DNAJC co-chaperone TCAIM as a selective OGDH-binding protein that lowers functional OGDH through HSPA9 and LONP1. This noncanonical proteostasis mechanism reduces OGDH complex activity and changes carbohydrate catabolism in cultured cells and murine models, highlighting a post-translational route for tuning mitochondrial metabolism.
-
DAMGO: µ-Opioid Receptor Agonist Research
2026-09-23
DAMGO provides a selective way to connect µ-opioid receptor activation with cellular signaling, tissue physiology, and pain-circuit behavior. This guide translates receptor pharmacology and recent mouse findings into practical workflows for opioid receptor signaling research, chronic pain research, and assay troubleshooting.
-
2',7'-Dichlorofluorescein diacetate for ROS
2026-09-22
Build a practical intracellular ROS measurement workflow for microscopy, flow cytometry, and plate assays using a broadly responsive fluorescent probe. The guide also shows how redox readouts can support evaluation of ROS-responsive nanocarriers in pancreatic cancer models without overstating probe specificity.
-
Central Control of Opioid Mechanical Hypersensitivity
2026-09-22
A 2024 Neuron study identifies a brain-to-spinal µ-opioid receptor pathway that links repeated morphine exposure to mechanical hypersensitivity and analgesic tolerance in mice. Its circuit-level evidence separates mechanical pain consequences from better-characterized thermal effects and provides a framework for testing receptor-selective interventions in opioid receptor signaling research.
-
Dual SMAD/Wnt Inhibition for iPSC-RGC Differentiation
2026-09-21
The reference study presents a chemically defined strategy that combines SMAD and canonical Wnt inhibition to produce retinal ganglion cells from induced pluripotent stem cells with improved yield and reproducibility. The workflow generated retinal ganglion cell populations exceeding 80% purity and increased enrichment to nearly 95% using CD90.2-based magnetic sorting, offering a practical foundation for glaucoma modeling and retinal neurobiology.
-
GCG Disrupts SARS-CoV-2 Nucleocapsid Condensation
2026-09-21
The reference study identifies RNA-triggered liquid–liquid phase separation by the SARS-CoV-2 nucleocapsid protein as a mechanistic step in viral organization and replication. It further shows that (-)-gallocatechin gallate disrupts N–RNA condensation and suppresses viral replication, providing a framework for studying antiviral intervention at biomolecular condensates.
-
HyperFusion high-fidelity DNA polymerase for PCR
2026-09-20
HyperFusion™ high-fidelity DNA polymerase combines proofreading accuracy, speed, blunt-end generation, and inhibitor tolerance for difficult C. elegans PCR targets. This workflow-oriented guide shows how to apply it to genotyping, cloning, and sequencing studies inspired by pheromone-driven neurodegeneration research.